Literature DB >> 11090096

Endothelial dysfunction in atherosclerotic mice: improved relaxation by combined supplementation with L-arginine-tetrahydrobiopterin and enhanced vasoconstriction by endothelin.

J Jiang1, G Valen, S Tokuno, P Thorén, J Pernow.   

Abstract

1. Mice lacking the apolipoprotein E and low density lipoprotein receptor genes (E degrees xLDLR degrees ) develop atherosclerosis and endothelial dysfunction. The aim of this study was to characterize the roles of L-arginine and tetrahydrobiopterin (BH(4)) for endothelium-dependent relaxation and the changes in the vasoconstrictor response to endothelin-1 (ET-1) in thoracic aortic rings of E degrees xLDLR degrees mice. 2. Histological examination revealed severe atherosclerosis of the thoracic aorta of E degrees xLDLR degrees mice. Relaxations induced by acetylcholine (Ach), but not that to sodium nitroprusside, were significantly impaired in E degrees xLDLR degrees mice compared to control mice indicating attenuated endothelium-dependent relaxations. 3. Preincubation with the nitric oxide (NO) substrate L-arginine did not affect, whereas the co-factor for NO synthase, BH(4), slightly improved the relaxations induced by Ach. Combined preincubation with L-arginine and BH(4) induced a pronounced enhancement of Ach-induced relaxations in E degrees xLDLR degrees mice. The relaxations induced by Ach in E degrees xLDLR degrees mice in the presence of L-arginine and BH(4) were not different from those observed in control mice. 4. Preincubation with superoxide dismutase did not affect Ach-induced relaxations in aorta from E degrees xLDLR degrees mice. 5. The contractile response to ET-1 was enhanced in E degrees xLDLR degrees mouse aorta. The contractions were abolished by the ET(A) receptor antagonist LU 135252. The ET(B) receptor agonist sarafotoxin 6c did not induce contractions or relaxations. 6. It is concluded that endothelial dysfunction of E degrees xLDLR degrees mouse aorta is reversed by combined administration of L-arginine and BH(4). In addition, the ET(A) receptor-mediated vasoconstriction by ET-1 is enhanced in E degrees xLDLR degrees mice.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11090096      PMCID: PMC1572463          DOI: 10.1038/sj.bjp.0703705

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  34 in total

Review 1.  Nitric oxide: physiology, pathophysiology, and pharmacology.

Authors:  S Moncada; R M Palmer; E A Higgs
Journal:  Pharmacol Rev       Date:  1991-06       Impact factor: 25.468

Review 2.  Atherosclerosis and the two faces of endothelial nitric oxide synthase.

Authors:  R M Wever; T F Lüscher; F Cosentino; T J Rabelink
Journal:  Circulation       Date:  1998 Jan 6-13       Impact factor: 29.690

Review 3.  Endothelial dysfunction: clinical implications.

Authors:  H Drexler
Journal:  Prog Cardiovasc Dis       Date:  1997 Jan-Feb       Impact factor: 8.194

4.  Tetrahydrobiopterin alters superoxide and nitric oxide release in prehypertensive rats.

Authors:  F Cosentino; S Patton; L V d'Uscio; E R Werner; G Werner-Felmayer; P Moreau; T Malinski; T F Lüscher
Journal:  J Clin Invest       Date:  1998-04-01       Impact factor: 14.808

Review 5.  Tetrahydrobiopterin and endothelial function.

Authors:  F Cosentino; T F Lüscher
Journal:  Eur Heart J       Date:  1998-07       Impact factor: 29.983

6.  Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice.

Authors:  M Barton; C C Haudenschild; L V d'Uscio; S Shaw; K Münter; T F Lüscher
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

Review 7.  Tetrahydrobiopterin, cytokines, and nitric oxide synthesis.

Authors:  E R Werner; G Werner-Felmayer; B Mayer
Journal:  Proc Soc Exp Biol Med       Date:  1998-12

8.  Endothelial dysfunction of the coronary microvasculature is associated with coronary blood flow regulation in patients with early atherosclerosis.

Authors:  A M Zeiher; H Drexler; H Wollschläger; H Just
Journal:  Circulation       Date:  1991-11       Impact factor: 29.690

9.  Vascular endothelial cells synthesize nitric oxide from L-arginine.

Authors:  R M Palmer; D S Ashton; S Moncada
Journal:  Nature       Date:  1988-06-16       Impact factor: 49.962

Review 10.  Catalysis by nitric oxide synthase.

Authors:  M A Marletta; A R Hurshman; K M Rusche
Journal:  Curr Opin Chem Biol       Date:  1998-10       Impact factor: 8.822

View more
  8 in total

1.  Modulation of NO and ROS production by AdiNOS transduced vascular cells through supplementation with L-Arg and BH4: implications for gene therapy of restenosis.

Authors:  Scott P Forbes; Ivan S Alferiev; Michael Chorny; Richard F Adamo; Robert J Levy; Ilia Fishbein
Journal:  Atherosclerosis       Date:  2013-06-29       Impact factor: 5.162

2.  Cardioprotective effect of an endothelin receptor antagonist during ischaemia/reperfusion in the severely atherosclerotic mouse heart.

Authors:  Adrian T Gonon; Alexander Bulhak; Anders Bröijersén; John Pernow
Journal:  Br J Pharmacol       Date:  2005-03       Impact factor: 8.739

3.  Endothelium dysfunction in LDL receptor knockout mice: a role for H2O2.

Authors:  Luíza A Rabelo; Steyner F Cortes; Jacqueline I Alvarez-Leite; Virgínia S Lemos
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

4.  The ratio between tetrahydrobiopterin and oxidized tetrahydrobiopterin analogues controls superoxide release from endothelial nitric oxide synthase: an EPR spin trapping study.

Authors:  Jeannette Vásquez-Vivar; Pavel Martásek; Jennifer Whitsett; Joy Joseph; Balaraman Kalyanaraman
Journal:  Biochem J       Date:  2002-03-15       Impact factor: 3.857

5.  Enhancing eNOS activity with simultaneous inhibition of IKKβ restores vascular function in Ins2(Akita+/-) type-1 diabetic mice.

Authors:  Manickam Krishnan; Preethi Janardhanan; Linda Roman; Robert L Reddick; Mohan Natarajan; Rien van Haperen; Samy L Habib; Rini de Crom; Sumathy Mohan
Journal:  Lab Invest       Date:  2015-07-27       Impact factor: 5.662

6.  Extracellular arginine rapidly dilates in vivo intestinal arteries and arterioles through a nitric oxide mechanism.

Authors:  Laura Pezzuto; H Glenn Bohlen
Journal:  Microcirculation       Date:  2008-02       Impact factor: 2.628

Review 7.  Boldine Ameliorates Vascular Oxidative Stress and Endothelial Dysfunction: Therapeutic Implication for Hypertension and Diabetes.

Authors:  Yeh Siiang Lau; Wei Chih Ling; Dharmani Murugan; Mohd Rais Mustafa
Journal:  J Cardiovasc Pharmacol       Date:  2015-06       Impact factor: 3.105

Review 8.  Mouse models of atherosclerosis and their suitability for the study of myocardial infarction.

Authors:  Pelin Golforoush; Derek M Yellon; Sean M Davidson
Journal:  Basic Res Cardiol       Date:  2020-11-30       Impact factor: 17.165

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.